Long-term survival of a young woman with peripheral cholangiocarcinoma: A case report

Journal of Clinical Gastroenterology

Volumn 28, Issue 1, 1999, Pages 64-66

  Marvin, Michael R ^a   Lefkowitch, Jay ^a   Ishak, Kamal G ^b   Chabot, John ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Cholangiocarcinoma; Intrahepatic; Peripheral; Survival

Indexed keywords

FLUOROURACIL; LEVAMISOLE;

ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CASE REPORT; FEMALE; HUMAN; HUMAN TISSUE; LIVER LOBECTOMY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHEMOTHERAPY, ADJUVANT; CHOLANGIOCARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HEPATECTOMY; HUMANS; LEVAMISOLE; TIME FACTORS;

EID: 0032895411     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199901000-00017     Document Type: Article

References (23)

1. Edmonson HA, Steiner PE. Primary carcinoma of the liver. Cancer 1954;7:462-500.
2. Kawarada Y, Mizumoto R. Cholangiocellular carcinoma of the liver. Am J Surg 1984;147:354-359.
3. Nakeeb A, Pitt HA, Lilemoe KD, et al. Cholangiocarcinoma, a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996;224:463-75.
4. Pitt HA, Dooley WC, Yeo CJ, et al. Malignancies of the biliary tree. Curr Probl Surg 1995;22:1-100.
5. Kawarada Y, Mizumoto R. Diagnosis and treatment of cholangiocellular carcinoma of the liver. Hepatogastroenterology 1990;37: 176-81.
6. Schlinkert RT, Nagorney DM, Van Heerden JA, et al. Intrahepatic cholangiocarcinoma: clinical aspects, pathology, and treatment. HPB Surg 1992;5:95-102.
7. Chen MF, Jan YY, Wang CS, et al. Clinical experience in 20 hepatic resections for peripheral cholangiocarcinoma. Cancer 1989;64:2226-32.
8. Rockwell G, Baker JW, Lasersohn JT. Cholangiocarcinoma of the liver. Case report with seven-year survival, with review of the literature on primary liver tumors and hepatic resection. Cancer 1966;19:1177-84.
9. Alpert LI, Zak FG, Werthamer S. Cholangiocarcinoma. A clinico-pathological study of five cases with ultrastructural observations. Hum Pathol 1974;5:709-28.
10. Izumi T, Shimizu K, Kiriyama M, et al. Long-term survival of peripheral intrahepatic cholangiocarcinoma with distant metastasis. Am J Gastroenterol 1995;90:505-7.
11. Cherqui D, Tantawi B, Alon R, et al. Intrahepatic cholangiocarcinoma - results of aggressive surgical management. Arch Surg 1995;130:1073-8.
12. Altaee MY, Johnson PJ, Farrant JM, et al. Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma. Cancer 1991;68:2051-5.
13. Sell S, Dunsfor HA. Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol 1989; 134:1347-60.
14. Yeo CJ, Pitt JA, Cameron JL. Cholangiocarcinoma. Surg Clin North Am 1990;70:1429-47.
15. Chou FF, Sheen-Chen SM, Chen CL, et al. Prognostic factors of resectable intrahepatic cholangiocarcinoma. J Surg Oncol 1995; 59;40.
16. Jan YY, Jeng LB, Hwang TL, et al. Factors influencing survival after hepatectomy for peripheral cholangiocarcinoma. Hepatogastroenterology 1997;43:614.
17. Pichlmayr R, Lamesch P, Weimann A, et al. Surgical treatment of cholangiocellular carcinoma. World J Surg 1995;19:83.
18. De Via VT, Hellman S, Rosenberg SA. Cancer: principles and practice of oncology, 4th ed. Philadelphia: JB Lippincott, 1993.
19. Chijiwa K, Ohsato T, Shinohara M, et al. Clinico-pathological findings of asymptomatic intrahepatic cholangiocellular carcinoma: report of two cases and review of the literature. Eur J Surg Oncol 1996;22:186-8.
20. Yamamoto J, Kosuge T, Takayama T, et al. Surgical treatment of cholangiocarcinoma. Surgery 1992;111:617-22.
21. Shiina T, Mikuriya S, Uno T, et al. Radiotherapy of cholangiocarcinoma. Cancer Chemother Pharmacol 1992;31:S115-8.
22. Stillwagon GB, Order SE, Klein JL, et al. Multi-modality treatment of primary nonresectable intrahepatic cholangiocarcinoma with I-131 anti-CEA. Int J Radiat Oncol Biol Phys 1987;13:687-95.
23. Stillwagon GB, Order SE, Haulk T, et al. Variable low dose rate irradiation (I-131-anti-CEA) and integrated low dose chemotherapy in the treatment of nonresectable primary intrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 1991;21:1601-5.